Citius Pharmaceuticals, Inc. short interest in 2023
In 2023, Citius Pharmaceuticals, Inc.'s disclosed short interest ran from 7.44% of shares outstanding on 13 Jan 2023 to 9.20% on 29 Dec 2023, a change of +1.76 percentage points. The year's high was 13.09% on 31 Jul 2023 and its low 7.44% on 13 Jan 2023, averaging 9.83% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 44.32 days on 31 Aug 2023. Full history: Citius Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 7.44% (13 Jan 2023)
- End of year
- 9.20% (29 Dec 2023)
- Change
- +1.76 pp
- High
- 13.09% (31 Jul 2023)
- Low
- 7.44% (13 Jan 2023)
- Average
- 9.83%
- Highest days to cover
- 44.32 (31 Aug 2023)
- SEC filings marked
- 7
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 7.44% | 22.17 | |
| 31 Jan 2023 | 7.93% | 6.28 | |
| 15 Feb 2023 | 7.50% | 14.49 | 10-Q filed, results (8-K) |
| 28 Feb 2023 | 7.72% | 21.16 | |
| 15 Mar 2023 | 7.83% | 16.95 | |
| 31 Mar 2023 | 8.19% | 22.21 | |
| 14 Apr 2023 | 8.72% | 10.49 | |
| 28 Apr 2023 | 9.30% | 8.66 | |
| 15 May 2023 | 7.63% | 4.17 | 10-Q filed, results (8-K) |
| 31 May 2023 | 8.66% | 9.24 | |
| 15 Jun 2023 | 9.23% | 12.46 | |
| 30 Jun 2023 | 11.81% | 6.16 | |
| 14 Jul 2023 | 12.83% | 16.12 | |
| 31 Jul 2023 | 13.09% | 10.52 | |
| 15 Aug 2023 | 12.50% | 14.77 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 12.36% | 44.32 | |
| 15 Sep 2023 | 12.22% | 16.10 | |
| 29 Sep 2023 | 11.67% | 32.78 | |
| 13 Oct 2023 | 10.83% | 39.08 | |
| 31 Oct 2023 | 10.63% | 20.08 | |
| 15 Nov 2023 | 10.09% | 37.41 | |
| 30 Nov 2023 | 9.97% | 42.02 | |
| 15 Dec 2023 | 8.47% | 22.84 | |
| 29 Dec 2023 | 9.20% | 28.91 | 10-K filed |
See also: Citius Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.